Wiley
Annals of Neurology
,  volume 85 ,  issue 6 ,  pages 907-920

Activation of nicotinamide adenine dinucleotide phosphate oxidase is the primary trigger of epileptic seizures in rodent models

Publication type: Journal Article
Publication date: 2019-04-12
Wiley
scimago Q1
wos Q1
SJR: 3.736
CiteScore: 15.9
Impact factor: 7.7
ISSN: 03645134, 15318249
DOI:  10.1002/ana.25474
PubMed ID:  30937971
Neurology
Neurology (clinical)
Abstract
Despite decades of epilepsy research, 30% of focal epilepsies remain resistant to antiseizure drugs, with effective drug development impeded by lack of understanding on how seizures are initiated. Here, we report the mechanism of seizure onset relevant to most seizures that are characteristic of focal epilepsies.
Found 
Found 

Top-30

Journals

1
2
3
Antioxidants
Antioxidants, 3, 9.09%
Antioxidants
3 publications, 9.09%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 3, 9.09%
International Journal of Molecular Sciences
3 publications, 9.09%
Molecules
Molecules, 2, 6.06%
Molecules
2 publications, 6.06%
Frontiers in Pharmacology
Frontiers in Pharmacology, 2, 6.06%
Frontiers in Pharmacology
2 publications, 6.06%
Free Radical Biology and Medicine
Free Radical Biology and Medicine, 2, 6.06%
Free Radical Biology and Medicine
2 publications, 6.06%
Redox Biology
Redox Biology, 2, 6.06%
Redox Biology
2 publications, 6.06%
Communications Biology
Communications Biology, 1, 3.03%
Communications Biology
1 publication, 3.03%
Frontiers in Cellular Neuroscience
Frontiers in Cellular Neuroscience, 1, 3.03%
Frontiers in Cellular Neuroscience
1 publication, 3.03%
Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience, 1, 3.03%
Frontiers in Molecular Neuroscience
1 publication, 3.03%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 1, 3.03%
Frontiers in Cell and Developmental Biology
1 publication, 3.03%
Neurotherapeutics
Neurotherapeutics, 1, 3.03%
Neurotherapeutics
1 publication, 3.03%
Trends in Pharmacological Sciences
Trends in Pharmacological Sciences, 1, 3.03%
Trends in Pharmacological Sciences
1 publication, 3.03%
Neuropharmacology
Neuropharmacology, 1, 3.03%
Neuropharmacology
1 publication, 3.03%
Neurobiology of Disease
Neurobiology of Disease, 1, 3.03%
Neurobiology of Disease
1 publication, 3.03%
Epilepsia
Epilepsia, 1, 3.03%
Epilepsia
1 publication, 3.03%
Advanced Materials Technologies
Advanced Materials Technologies, 1, 3.03%
Advanced Materials Technologies
1 publication, 3.03%
Neural Regeneration Research
Neural Regeneration Research, 1, 3.03%
Neural Regeneration Research
1 publication, 3.03%
Journal of Neurology
Journal of Neurology, 1, 3.03%
Journal of Neurology
1 publication, 3.03%
eNeuro
eNeuro, 1, 3.03%
eNeuro
1 publication, 3.03%
Progress in Neurobiology
Progress in Neurobiology, 1, 3.03%
Progress in Neurobiology
1 publication, 3.03%
Brain Research
Brain Research, 1, 3.03%
Brain Research
1 publication, 3.03%
Cytokine and Growth Factor Reviews
Cytokine and Growth Factor Reviews, 1, 3.03%
Cytokine and Growth Factor Reviews
1 publication, 3.03%
1
2
3

Publishers

2
4
6
8
10
Elsevier
Elsevier, 10, 30.3%
Elsevier
10 publications, 30.3%
MDPI
MDPI, 8, 24.24%
MDPI
8 publications, 24.24%
Springer Nature
Springer Nature, 5, 15.15%
Springer Nature
5 publications, 15.15%
Frontiers Media S.A.
Frontiers Media S.A., 5, 15.15%
Frontiers Media S.A.
5 publications, 15.15%
Wiley
Wiley, 2, 6.06%
Wiley
2 publications, 6.06%
Ovid Technologies (Wolters Kluwer Health)
Ovid Technologies (Wolters Kluwer Health), 1, 3.03%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 3.03%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 3.03%
Cold Spring Harbor Laboratory
1 publication, 3.03%
Society for Neuroscience
Society for Neuroscience, 1, 3.03%
Society for Neuroscience
1 publication, 3.03%
2
4
6
8
10
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
33
Share
Cite this
GOST |
Cite this
GOST Copy
Malkov A. et al. Activation of nicotinamide adenine dinucleotide phosphate oxidase is the primary trigger of epileptic seizures in rodent models // Annals of Neurology. 2019. Vol. 85. No. 6. pp. 907-920.
GOST all authors (up to 50) Copy
Malkov A., Ivanov A., Latyshkova A., Bregestovski P., Zilberter M., Zilberter Y. Activation of nicotinamide adenine dinucleotide phosphate oxidase is the primary trigger of epileptic seizures in rodent models // Annals of Neurology. 2019. Vol. 85. No. 6. pp. 907-920.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/ana.25474
UR - https://doi.org/10.1002/ana.25474
TI - Activation of nicotinamide adenine dinucleotide phosphate oxidase is the primary trigger of epileptic seizures in rodent models
T2 - Annals of Neurology
AU - Malkov, Anton
AU - Ivanov, Anton
AU - Latyshkova, Alexandra
AU - Bregestovski, Piotr
AU - Zilberter, Misha
AU - Zilberter, Yuri
PY - 2019
DA - 2019/04/12
PB - Wiley
SP - 907-920
IS - 6
VL - 85
PMID - 30937971
SN - 0364-5134
SN - 1531-8249
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Malkov,
author = {Anton Malkov and Anton Ivanov and Alexandra Latyshkova and Piotr Bregestovski and Misha Zilberter and Yuri Zilberter},
title = {Activation of nicotinamide adenine dinucleotide phosphate oxidase is the primary trigger of epileptic seizures in rodent models},
journal = {Annals of Neurology},
year = {2019},
volume = {85},
publisher = {Wiley},
month = {apr},
url = {https://doi.org/10.1002/ana.25474},
number = {6},
pages = {907--920},
doi = {10.1002/ana.25474}
}
MLA
Cite this
MLA Copy
Malkov, Anton, et al. “Activation of nicotinamide adenine dinucleotide phosphate oxidase is the primary trigger of epileptic seizures in rodent models.” Annals of Neurology, vol. 85, no. 6, Apr. 2019, pp. 907-920. https://doi.org/10.1002/ana.25474.